Hydroxamic acid derivatives
US9096627B2 · kind B2 · utility
25Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 2013 |
| Grant date | Aug 4, 2015 |
| Priority date | — |
| Expiry date | Nov 8, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a method of alleviating, relieving, altering, remedying, ameliorating, improving or affecting a neoplastic disease or an immune disease, the method comprising administering to a subject in need thereof an effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof:wherein P, Z, and m are defined herein above.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.